Corticosteroid therapy is commonly used among critically ill patients with the Middle East Respiratory Syndrome (MERS), but its impact on outcomes is uncertain. Analyses of observational studies often do not account for patients’ clinical condition at the time of corticosteroid therapy initiation.
To investigate the association of corticosteroid therapy on mortality and on MERS coronavirus RNA clearance in critically ill patients with MERS.Expand abstract
- Publication status:
- Peer review status:
- Peer reviewed
- Accepted manuscript
- American Thoracic Society Journals Publisher's website
- American Journal of Respiratory and Critical Care Medicine Journal website
- Publication date:
- Acceptance date:
- Pubs id:
- Local pid:
- Copyright holder:
- American Thoracic Society
- Copyright date:
- Copyright © 2017 American Thoracic Society, All Rights Reserved.
Corticosteroid therapy for critically ill patients with the Middle East Respiratory Syndrome.
If you are the owner of this record, you can report an update to it here: Report update to this record